Analysts think CSTL stock price could increase by 89%
Mar 10, 2026, 11:25 AM
-8.03%
What does CSTL do
Castle Biosciences, headquartered in Friendswood, Texas, is a dermatological cancer company that provides genomic tests for skin cancers and mental health conditions. The firm went public in July 2019 and employs 610 people.
10 analysts think CSTL stock price will increase by 88.82%. The current median analyst target is $51.00 compared to a current stock price of $27.01. The lowest analysts target is $41.41 and the highest analyst target is $54.60.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.